TG Therapeutics (TGTX) stock drops 7% as JPMorgan healthcare conference nears — what investors watch next

TG Therapeutics (TGTX) stock drops 7% as JPMorgan healthcare conference nears — what investors watch next

New York, January 9, 2026, 15:59 (EST) — Regular session TG Therapeutics (TGTX.O) shares fell about 7% on Friday, reversing an early rise and leaving the biotech near its session low. The stock was down 7% at $28.35 by 3:55 p.m. EST after opening at $30.69 and sliding as low as $28.215. It hit $30.83 earlier in the session. The move comes with the J.P. Morgan Healthcare Conference set to kick off on Monday in San Francisco, a meeting that often pulls in fresh corporate updates and deal chatter in one tight week. The bank’s agenda shows the event runs
9 January 2026
Microsoft stock holds near $480 as Copilot Checkout rollout sets up a Jan. 28 earnings test

Microsoft stock holds near $480 as Copilot Checkout rollout sets up a Jan. 28 earnings test

New York, January 9, 2026, 16:12 ET — After-hours Microsoft Corp shares gained 0.2% to $479.07 on Friday after the software maker leaned further into retail, rolling out a new Copilot checkout feature alongside other AI tools. The company is valued at about $3.85 trillion. Timing is key: Microsoft said it will report fiscal 2026 second-quarter results after the market closes on Jan. 28, a read on demand across its cloud and AI businesses. Investors will also be listening for any change in its outlook for the rest of the fiscal year. (Source) On Thursday, Microsoft rolled out “agentic AI”
Micron stock jumps 5% on Moody’s upgrade, Mizuho target hike as memory bets return

Micron stock jumps 5% on Moody’s upgrade, Mizuho target hike as memory bets return

NEW YORK, Jan 9, 2026, 16:05 EST — After-hours Micron Technology shares rose on Friday after Moody’s upgraded the memory-chip maker’s senior unsecured rating to Baa2 from Baa3, keeping its outlook stable, and an analyst lifted his price target. The stock was last up 5.1% at $343.71, after trading between $326.41 and $345.74. (Investing.com) The calls matter because Micron sits at the center of a trade investors keep circling back to: tighter supply in advanced memory as data centers add more compute. High-bandwidth memory, or HBM — stacked dynamic random access memory used alongside AI accelerator chips — has been
Polestar stock drops despite “best year ever” sales; Feb. 18 update is next test

Polestar stock drops despite “best year ever” sales; Feb. 18 update is next test

New York, Jan 9, 2026, 15:56 EST — Regular session Polestar Automotive Holding UK PLC shares fell 5.9% to $20.90 at 3:56 p.m. EST, swinging between $20.81 and $22.35 in Friday’s Nasdaq session. In an SEC filing, the electric-vehicle maker put 2025 retail sales at about 60,119 cars, up 34%, and said fourth-quarter volumes rose 27% to 15,608; it said the figures were preliminary and could be adjusted. CEO Michael Lohscheller called 2025 its “best year ever” for retail volumes and set Feb. 18 for a strategy update; Polestar said a December ADS ratio change — akin to a reverse
Intel stock jumps nearly 10% after Trump praise; earnings in focus

Intel stock jumps nearly 10% after Trump praise; earnings in focus

NEW YORK, Jan 9, 2026, 16:05 EST — After-hours Intel Corp shares jumped on Friday, closing up 9.8% at $45.13 after President Donald Trump praised Chief Executive Lip-Bu Tan following a White House meeting. The stock touched $45.22 intraday, with about 120 million shares traded. (Yahoo Finance) The move matters because Intel is heading into a closely watched earnings report with momentum — and little room for surprises. The company said it will report fourth-quarter and full-year 2025 results after the market close on Jan. 22. (Newsroom) Trump met Tan on Thursday, according to a Bloomberg report that said the
Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

New York, Jan 9, 2026, 15:52 EST — Regular session Shares of Hims & Hers Health, Inc (HIMS.N) fell 5.3% to $32.06 on Friday, after Amazon Pharmacy said it now offers Novo Nordisk’s Wegovy weight-loss pill, raising the pressure on telehealth sellers chasing obesity drug demand. The stock hit an intraday high of $34.35 before sliding to a session low of $32.06. (Reuters) The move matters because weight-loss has become a key battleground for online healthcare platforms, and the market has started to treat GLP-1 drugs — medicines that can curb appetite and drive weight loss — as a price
Why iRhythm stock is sliding today as Wall Street looks to JPM Healthcare Conference

Why iRhythm stock is sliding today as Wall Street looks to JPM Healthcare Conference

New York, Jan 9, 2026, 15:54 EST — Regular session Shares of iRhythm Technologies (IRTC.O) fell 3.9% to $181.95 on Friday, after swinging between $190.16 and $179.61 in the session. The stock ended Thursday at $189.25. The drop left iRhythm behind a broader advance in U.S. equities, with S&P 500 and Nasdaq-tracking funds up about 0.8% and 1.1%, respectively. That gap matters because iRhythm trades like a growth stock — sensitive to rate moves and risk appetite — and those currents can swamp stock-specific news for stretches. A Labor Department report showed nonfarm payrolls — a broad count of jobs
9 January 2026
Las Vegas Sands stock slides as Macau margin jitters flare — what investors are watching next

Las Vegas Sands stock slides as Macau margin jitters flare — what investors are watching next

New York, January 9, 2026, 15:40 (EST) — Regular session Las Vegas Sands shares were down about 4.3% at $59.25 in afternoon trade on Friday, after touching a session low near $59.18. The drop matters now because Sands is one of the U.S. market’s purest plays on Macau casinos, where small swings in costs and promotions can move profits quickly. Traders have been quick to fade anything that hints at weaker margins going into the next round of quarterly reports. JPMorgan said it had been fielding calls from dozens of investors after shares of Hong Kong-listed Sands China fell 4.5%
9 January 2026
Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

New York, Jan 9, 2026, 15:46 EST — Regular session Arcutis Biotherapeutics shares slid 5.3% to $28.29 in afternoon trading on Friday, after climbing as high as $30.70 earlier. The stock was last at the session low. The move followed a cooler U.S. payrolls report, which reinforced expectations the Federal Reserve will keep rates steady in coming weeks. High-growth biotech names can swing hard when the rate outlook gets murkier. (Reuters) Broader biotech held up better. The S&P biotech ETF XBI and the iShares Nasdaq Biotechnology ETF IBB were both higher, tracking gains in the S&P 500 and Nasdaq-100 ETFs.
Intuitive Machines (LUNR) stock slides after Stifel downgrade as NASA moon rover decision nears

Intuitive Machines (LUNR) stock slides after Stifel downgrade as NASA moon rover decision nears

New York, January 9, 2026, 15:44 EST — Regular session Intuitive Machines Inc shares were down 3.8% at $18.88 on Friday afternoon, after a choppy session that took the stock from $17.82 to $19.73. About 14.0 million shares changed hands, a heavy day for the name. The slide came after a Stifel downgrade. The firm cut the stock to “hold” from “buy,” even as it raised its price target to $20 from $18. Analyst Jonathan Siegmann said Stifel is seeing “increased nervousness” ahead of NASA’s Lunar Terrain Vehicle decision, which he called “imminent,” and cautioned that politics could complicate the
Valero Energy stock dips on Piper Sandler target cut as Venezuela talks keep traders guessing

Valero Energy stock dips on Piper Sandler target cut as Venezuela talks keep traders guessing

New York, Jan 9, 2026, 15:36 EST — Regular session Valero Energy Corp (NYSE: VLO) shares were down $5.82, or about 3%, at $185.50 in mid-afternoon trade, after swinging between $182.70 and $194.50. Marathon Petroleum was little changed and Phillips 66 fell about 1.2%, while the SPDR S&P 500 ETF Trust rose 0.8%. The move matters now because refiners are trying to price a fast-shifting crude story into near-term earnings. Crack spreads — the gap between crude costs and fuel prices — can swing quickly when geopolitics hits supply, and investors have been quick to fade the latest headlines. U.S.
Constellation Brands stock edges up after earnings beat, but Modelo demand warning lingers

Constellation Brands stock edges up after earnings beat, but Modelo demand warning lingers

NEW YORK, Jan 9, 2026, 15:37 EST — Regular session Constellation Brands, Inc. shares edged higher on Friday as investors digested the brewer’s trimmed profit outlook and a blunt message from management that beer demand is still choppy. Shares were up 0.1% at $148.13, after trading between $146.12 and $149.72 in the session. Constellation beat quarterly sales and profit estimates on Wednesday, then cut its fiscal 2026 earnings-per-share outlook to $9.72-$10.02 from $9.86-$10.16 and reiterated a 4% to 6% decline in organic net sales — a measure that strips out the impact of acquisitions and divestitures — for the year
9 January 2026

Stock Market Today

Plug Power stock jumps 12% after vote setback, with Feb 17 share decision in focus

Plug Power stock jumps 12% after vote setback, with Feb 17 share decision in focus

7 February 2026
New York, February 7, 2026, 06:32 EST — Market closed. Plug Power Inc shares jumped 11.6% on Friday to close at $2.08, snapping a two-day slide as investors headed into the weekend focused on a delayed shareholder vote that could reshape how the hydrogen company funds itself. Trading volume was about 109 million shares, and fuel-cell peer Ballard Power Systems gained about 5.9% on the day. (MarketWatch) The next session matters because the shareholder vote is no longer a sideshow. The outcome will determine whether Plug can expand the pool of stock it is allowed to issue, a key lever
AT&T stock price: T slips after $6.5B bond sale as payrolls, CPI loom next week

AT&T stock price: T slips after $6.5B bond sale as payrolls, CPI loom next week

7 February 2026
AT&T shares closed down 0.7% at $27.13 on Friday, underperforming the S&P 500’s 1.97% gain. The company completed a $6.5 billion global notes sale this week, with maturities from 2031 to 2056 and coupons between 4.4% and 6%. Investors await delayed U.S. jobs and inflation data, along with T-Mobile’s upcoming earnings update.
Go toTop